Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited)

v3.10.0.1
Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Total New Residential Stockholders’ Equity
Noncontrolling Interests in Equity of Consolidated Subsidiaries
Equity, beginning balance (in shares) at Dec. 31, 2016   250,773,117          
Equity, beginning balance at Dec. 31, 2016 $ 3,468,177 $ 2,507 $ 2,920,730 $ 210,500 $ 126,363 $ 3,260,100 $ 208,077
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared (454,877)     (454,877)   (454,877)  
Capital contributions 0           0
Capital distributions (70,493)           (70,493)
Issuance of common stock (in shares)   56,545,787          
Issuance of common stock 834,529 $ 566 833,963     834,529  
Other dilution (4,202)   (4,202)     (4,202)  
Purchase of noncontrolling interests in the Buyer (65,860)   9,183     9,183 (75,043)
Director share grants (in shares)   42,405          
Director share grants 699 $ 1 698     699 0
Comprehensive income (loss)              
Net income (loss) 714,282     669,231   669,231 45,051
Net unrealized gain (loss) on securities 277,805       277,805 277,805  
Reclassification of net realized (gain) loss on securities into earnings (20,856)       (20,856) (20,856)  
Total comprehensive income (loss) 971,231         926,180 45,051
Equity, ending balance (in shares) at Sep. 30, 2017   307,361,309          
Equity, ending balance at Sep. 30, 2017 4,679,204 $ 3,074 3,760,372 424,854 383,312 4,571,612 107,592
Equity, beginning balance (in shares) at Dec. 31, 2017   307,361,309          
Equity, beginning balance at Dec. 31, 2017 4,796,162 $ 3,074 3,763,188 559,476 364,467 4,690,205 105,957
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared (508,176)     (508,176)   (508,176)  
Capital contributions 0           0
Capital distributions (51,735)           (51,735)
Issuance of common stock (in shares)   29,241,659          
Issuance of common stock $ 491,604 $ 292 491,312     491,604  
Options exercise (in shares) 15,803,216 3,694,228          
Option exercise $ 0 $ 37 (37)     0  
Other dilution (63)   (63)     (63)  
Purchase of noncontrolling interests in the Buyer 8,075   627     627 7,448
Director share grants (in shares)   57,232.5688073394          
Director share grants 1,019 $ 1 1,018     1,019 0
Comprehensive income (loss)              
Net income (loss) 995,677     963,619   963,619 32,058
Net unrealized gain (loss) on securities 14,600       14,600 14,600  
Reclassification of net realized (gain) loss on securities into earnings 89,885       89,885 89,885  
Total comprehensive income (loss) 1,100,162         1,068,104 32,058
Equity, ending balance (in shares) at Sep. 30, 2018   340,354,429          
Equity, ending balance at Sep. 30, 2018 $ 5,837,048 $ 3,404 $ 4,256,045 $ 1,014,919 $ 468,952 $ 5,743,320 $ 93,728